LYCR728-210 exhibited strong binding affinity to both the DENV3 and ZIKV NS5 RdRp, with a binding free energy of −9.2 kcal/mol, and LYCS505-214 demonstrated dual inhibitory activity, suggesting its potential for treating co-infections. The gene discussed is RAF1; the disease is coinfection.